Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-20

Clinical Trial Update: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD) [NA]

View source ↗

Summary

This clinical trial is evaluating the efficacy and safety of Calculus Bovis Sativus (CBS) for idiopathic inflammatory demyelinating diseases, including multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calculus Bovis Sativus (Calculus Bovis Sativus)

Snippet

Sponsor: Tongji Hospital | Conditions: Idiopathic Inflammatory Demyelinating Disease, Multiple Sclerosis | NA | Status: RECRUITING